Cellevate
Cellevate is a spin out from NanoLund - a world leading nanomaterial academic center, part of Lund University in Sweden. The company develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - a game-changing, green and sustainable, deep-tech innovation for the biopharmaceutical industry. This platform allows for an industrial-scale production of nanofiber materials – “microcarriers” - with unparalleled surface area for cell growth, reproducibility and customization, which ultimately lead to an improved biomanufacturing productivity and process economy. Cellevat3d™ microcarriers products are designed as an integrated part of upstream bioprocess solutions, starting with laboratory testing of cell lines followed by pilot and large-scale batch production of novel classes of biological therapies, including cell- and gene therapies and vaccines. Cellevat3d™ microcarriers launch is planned for 2024.